Thromboprophylaxis in critical care

Julie Helms; Saskia Middeldorp; Alex C. Spyropoulos

doi:10.1007/s00134-022-06850-7

Thromboprophylaxis in critical care

Julie Helms^*
, Saskia Middeldorp
, Alex C. Spyropoulos

^*Corresponding author for this work

Université de Strasbourg
Inserm
Radboud University Medical Center
Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
hCenter for Psychiatric Neuroscience; The Feinstein Institutes for Medical Research, Manhasset, NY, USA
Lenox Hill Hospital

Research output: Contribution to journal › Article › Academic › peer-review

42 Downloads (Pure)

Original language	English
Pages (from-to)	75-78
Number of pages	4
Journal	Intensive care medicine
Volume	49
Issue number	1
Early online date	2022
DOIs	https://doi.org/10.1007/s00134-022-06850-7
Publication status	Published - Jan 2023

Access to Document

10.1007/s00134-022-06850-7

Thromboprophylaxis-in-critical-care.pdfFinal published version, 979 KBLicence: CC BY

Cite this

@article{fa4b6112f9c44aeaaebd443e980a0e9d,

title = "Thromboprophylaxis in critical care",

author = "Julie Helms and Saskia Middeldorp and Spyropoulos, \{Alex C.\}",

note = "Funding Information: JH has received honoraria for lectures from Diagnostica Stago, Pfizer PFE France and Sanofi Aventis France. SM has received personal fees from Daiichi Sankyo, Bayer, Pfizer, Boehringer Ingelheim, Portola/Alexion, AbbVie, BMS-Pfizer, Sanofi, and Viatris, all paid to her institution, and grants from Daiichi Sankyo, Bayer, Pfizer, and Boehringer Ingelheim. AS received consultant fees from Janssen, Bayer, Bristol Myer Squibb, Sanofi, Alexion, ATLAS Group and research Funds from Janssen.",

year = "2023",

month = jan,

doi = "10.1007/s00134-022-06850-7",

language = "English",

volume = "49",

pages = "75--78",

journal = "Intensive care medicine",

issn = "0342-4642",

publisher = "Springer Verlag",

number = "1",

}

TY - JOUR

T1 - Thromboprophylaxis in critical care

AU - Helms, Julie

AU - Middeldorp, Saskia

AU - Spyropoulos, Alex C.

N1 - Funding Information: JH has received honoraria for lectures from Diagnostica Stago, Pfizer PFE France and Sanofi Aventis France. SM has received personal fees from Daiichi Sankyo, Bayer, Pfizer, Boehringer Ingelheim, Portola/Alexion, AbbVie, BMS-Pfizer, Sanofi, and Viatris, all paid to her institution, and grants from Daiichi Sankyo, Bayer, Pfizer, and Boehringer Ingelheim. AS received consultant fees from Janssen, Bayer, Bristol Myer Squibb, Sanofi, Alexion, ATLAS Group and research Funds from Janssen.

PY - 2023/1

Y1 - 2023/1

UR - https://www.scopus.com/pages/publications/85137214580

U2 - 10.1007/s00134-022-06850-7

DO - 10.1007/s00134-022-06850-7

M3 - Article

C2 - 36038712

SN - 0342-4642

VL - 49

SP - 75

EP - 78

JO - Intensive care medicine

JF - Intensive care medicine

IS - 1

ER -

Thromboprophylaxis in critical care

Access to Document

Other files and links

Cite this